
via LabRoots
New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- CV Sciences (OTCMKTS:CVSI) Raised to Hold at Zacks Investment Researchon January 19, 2021 at 10:51 pm
Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is ...
- CBDfx Expands Pet Product Line With New CBD-Infused Pet Treatson January 19, 2021 at 10:17 pm
Leading CBD products company, CBDfx, is expanding its wildly popular, vegan CBD pet line with the addition of all-natural, crunchy Pet Treats targeted at two of the most common canine ailments: ...
- S.African wine and spirits maker Distell branches out into cannabis productson January 19, 2021 at 10:16 pm
South African wine, cider and spirits company Distell will soon be able to offer cannabidiol-infused drinks after taking a 20% stake in cannabis wellness business RETHINK, it said on Wednesday.
- Cannabidiol kills bacteria responsible for gonorrhea, meningitis, and legionnaires diseaseon January 19, 2021 at 9:18 pm
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.
- Woman who fought CBD drug charges dies from COVID-19 complicationson January 19, 2021 at 4:26 pm
That was her reaction when the Nebraska Supreme Court ruled her drug case should be thrown out. "It's been a struggle but we are hanging in there," she said. "I'm just thrilled we got the decision ...
- I Tried This CBD Subscription and I Recommend It to Everyoneon January 19, 2021 at 12:30 pm
Cannabidiol, or the stuff in hemp or weed that helps you feel calm without the munchies or a new affinity for animal documentaries, is basically everywhere now— a pack of CBD gummies at a gas station, ...
- CBD industry, retailers adapting to COVIDon January 19, 2021 at 10:42 am
Use of cannabidiol, better known as CBD, has grown exponentially in recent years, and products containing the cannabinoid have popped up on shelves in stores across America. The COVID-19 pandemic ...
- Research establishes antibiotic potential for cannabis moleculeon January 19, 2021 at 9:27 am
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.
- North America Hemp-derived Cannabidiol (CBD) Markets, 2020-2027: Market Size is Expected to Reach USD 16.1 Billion, Rising at a CAGR of 27.7%on January 19, 2021 at 7:33 am
Dublin, Jan. (GLOBE NEWSWIRE) -- The "North America Hemp-derived Cannabidiol Market Size, Share & Trends Analysis Report by Product Type (Hemp-derived ...
- CBD BRAND OPENS THE PERUVIAN MARKET (IN MORE WAYS THAN ONE)on January 18, 2021 at 4:02 pm
CBD BRAND & FIRST CBD CAPSULE PRODUCT REGISTERED IN PERU. ORLANDO, FL, UNITED STATES, 2021 /EINPresswire.com/ -- Cannabidiol Life, a Florida-based, GMP, USDA Organic manufacturing CBD brand, increase ...
via Bing News